Journal
CLINICAL INFECTIOUS DISEASES
Volume 49, Issue 2, Pages 306-309Publisher
UNIV CHICAGO PRESS
DOI: 10.1086/600044
Keywords
-
Categories
Funding
- FIC NIH HHS [D43TW00237, D43 TW000237] Funding Source: Medline
- NIAID NIH HHS [P30AI42853, R01 AI066922, U01AI069432, P30 AI042853, U01 AI069432] Funding Source: Medline
Ask authors/readers for more resources
Continuation of failed highly active antiretroviral therapy regimens can lead to the accumulation of mutations that may limit options for second-line treatment. We studied the pattern of drug resistance mutations among 138 Indian patients who experienced failure of nonnucleotide reverse-transcriptase-containing first-line highly active antiretroviral therapy. This study demonstrates a high frequency of drug resistance mutations in human immunodeficiency virus-infected Indians who experience immunologic treatment failure and suggests the need for viral load monitoring.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available